{"id":200,"date":"2026-06-10T16:14:54","date_gmt":"2026-06-10T15:14:54","guid":{"rendered":"https:\/\/7c71d11735.nxcli.io\/?page_id=200"},"modified":"2026-06-10T16:14:54","modified_gmt":"2026-06-10T15:14:54","slug":"haematology","status":"publish","type":"page","link":"https:\/\/nencmaternalmedicine.nhs.uk\/index.php\/professionals\/haematology\/","title":{"rendered":"Haematology"},"content":{"rendered":"
<\/div>

Haematology<\/h1><\/div><\/div><\/div><\/div><\/section>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div><\/section>

Referral criteria<\/h3>\n

For women requiring MMC led care they are often managed in the specialist Obstetric Haematology clinic on Monday afternoon\u2019s at the RVI<\/p>\n

Lead Maternal Medicine Obstetrician- Dr T Shears<\/p>\n

Lead Haematologist- Dr S Kazi<\/p>\n<\/div><\/div><\/div><\/div>

Clinical resources<\/h3>\n

British Society of Haematology- Guidelines for the management of sickle cell disease in pregnancy Guidelines for the Management of sickle cell disease in pregnancy<\/a><\/p>\n

British Society of Haematology- Guideline for the management of conception and pregnancy in thalassaemia syndromes Guideline for the Management of Conception and Pregnancy in Thalassaemia Syndromes<\/a><\/p>\n

British Society of Haematology- UK guidelines on the management of iron deficiency in pregnancy UK guidelines on the management of iron deficiency in pregnancy<\/a><\/p>\n

RCOG Green top guideline- Management of sickle cell disease in pregnancy<\/p>\n

Patient information<\/h3>\n

The Haemophilia Society- Haemophilia- Pregnancy and Childbirth Haemophilia \u2013 Pregnancy and Childbirth | The Haemophilia Society<\/a><\/p>\n

World federation of Haemophilia- Women and girls with Haemophilia pdf-2342.pdf<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>

\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Category A
\nLocal expertise<\/th>		Category B
\nReview, advice and guidance from maternal medicine centre<\/th>		Category C
\nCare led by maternal medicine centre<\/th>\n<\/tr>\n<\/thead>\n
Sickle cell trait<\/td>Current immune thrombocytopenia and platelet count \u2264<\/td>Sickle cell disease<\/td>\n<\/tr>\n
Historical immune thrombocytopenia and platelet count >75<\/td>Thrombocytosis<\/td>Beta thalassaemia major<\/td>\n<\/tr>\n
Gestational thrombocytopenia<\/td>White cell disorders<\/td>Complex thalassaemia
\nIron overload
\nEndocrine disease
\nPulmonary hypertension<\/td>\n<\/tr>\n
Current VTE or previous single VTE<\/td>Recurrent VTE<\/td>Current extensive VTE without other access to Factor Xa monitoring<\/td>\n<\/tr>\n
Obstetric antiphospholipid syndrome<\/td>Thrombotic antiphospholipid syndrome<\/td>Antiphospholipid syndrome with extensive arterial events<\/td>\n<\/tr>\n
Inherited thrombophilia (no VTE, not antithrombin deficiency)<\/td>Inherited thrombophilia with prvious VTE<\/td>Antithrombin deficiency<\/td>\n<\/tr>\n
History of treated haematological malignancy<\/td>Stable myeloproliferative\/myelodysplastic disease<\/td>Active haematological malignancy<\/td>\n<\/tr>\n
Alpha\/beta thalassaemia trait<\/td>Mild, isolated clotting factor deficiency
\nFactor II, V, XI or XIII>0.2iu\/ml
\nFactor X > 0.3iu\/ml
\n<\/td>		Clotting factor deficiency
\nFactor II, V,XI or XIII\u22640.2iu\/ml
\nFactor X \u22640.3iu\/ml
\nCombined deficiencies<\/td>\n<\/tr>\n
B12\/Folate deficiency<\/td>Mild platelet function disorder with platelet count >100<\/td>Moderate\/severe platelet function disorder or with platelet count >100<\/td>\n<\/tr>\n
<\/td>Carriers of haemophilia with known female fetus and normal factor VIII\/IX<\/td>Carriers of haemophillia with male or unknown gender of fetus<\/td>\n<\/tr>\n
<\/td>Type I Von-Willebrand disease, VWF activity normalised in pregnancy<\/td>Von-Willebrand disease: Type 1 if VWF not normalised Type II and Type III<\/td>\n<\/tr>\n
<\/td><\/td>Transfusion dependent disease<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"HaematologyReferral criteria For women requiring MMC led care they are often managed in the specialist Obstetric Haematology clinic on Monday afternoon\u2019s at the RVI Lead Maternal Medicine Obstetrician- Dr T Shears Lead Haematologist- Dr S Kazi Clinical resources British Society of Haematology- Guidelines for the management of sickle cell disease in pregnancy Guidelines for the...","protected":false},"author":1,"featured_media":0,"parent":86,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-200","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/nencmaternalmedicine.nhs.uk\/index.php\/wp-json\/wp\/v2\/pages\/200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nencmaternalmedicine.nhs.uk\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nencmaternalmedicine.nhs.uk\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nencmaternalmedicine.nhs.uk\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nencmaternalmedicine.nhs.uk\/index.php\/wp-json\/wp\/v2\/comments?post=200"}],"version-history":[{"count":1,"href":"https:\/\/nencmaternalmedicine.nhs.uk\/index.php\/wp-json\/wp\/v2\/pages\/200\/revisions"}],"predecessor-version":[{"id":201,"href":"https:\/\/nencmaternalmedicine.nhs.uk\/index.php\/wp-json\/wp\/v2\/pages\/200\/revisions\/201"}],"up":[{"embeddable":true,"href":"https:\/\/nencmaternalmedicine.nhs.uk\/index.php\/wp-json\/wp\/v2\/pages\/86"}],"wp:attachment":[{"href":"https:\/\/nencmaternalmedicine.nhs.uk\/index.php\/wp-json\/wp\/v2\/media?parent=200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}